While it is personally reassuring and useful for all to have scientific confirmation for this part of my clinical regimen for rosacea, limiting one's clinical regimen literally to the treatment evaluated by Dahl et al 3 could shortchange patients with rosacea and be hazardous to those with ocular involvement. One of the most compelling reasons for the specialty of dermatology is the need for clinicians who can interpret and transcend the science when caring for patients with skin disease. The views in this editorial are solely those of the author and are not necessarily the views of the Food and Drug Administration. Br J Dermatol. Dahl MV, Katz HI, Krueger GG, et al.
Topical metronidazole maintains remissions of rosacea.
J Invest Dermatol. Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. All rights reserved.